Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza vs Topical Steroids in RLE (PRIME)
NCT04549935Phase 4Recruiting
- Sponsor
- Vance Thompson Vision
- Start
- Sep 2020
- Primary completion
- Aug 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in post-operative inflammation, postoperative pain, sponsored by Vance Thompson Vision. Started Sep 2020; status: recruiting.
02
Drugs
ozurdex
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT04549935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04549935.